Mitapivat and Clindamycin: Interaction Details

Brand names
Clindamycin
CleocinClindacinXaciato +10 more
Mitapivat
PyrukyndAqvesme
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Clindamycin

Brand names
  • Cleocin
  • Clindacin
  • Xaciato
  • Clindagel
  • Clindamax
  • Clindesse
  • Cleocin-T
  • Cleocin Phosphate
  • Cleocin Hydrochloride
  • Clindacin P
  • Clindacin ETZ
  • Cleocin T
  • Cleocin Pediatric

Mitapivat

Brand names
  • Pyrukynd
  • Aqvesme

What Happens When You Take Mitapivat With Clindamycin

What can happen when they are taken together (rated Major)

Reduced exposure

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Mitapivat should not be used together with sensitive CYP3A substrates that have a . Because mitapivat induces CYP3A, giving it alongside a sensitive CYP3A substrate lowers that substrate's exposure.1

When the combination cannot be avoided, watch for a loss of therapeutic effect. Drug interaction studies using midazolam, a sensitive CYP3A substrate, showed that mitapivat reduced midazolam (inf) and by 21% and 19%, respectively, at 5 mg twice daily, by 43% and 39% at 20 mg twice daily, and by 57% and 52% at 50 mg twice daily.2 In the same way, mitapivat 100 mg twice daily lowered midazolam AUC (inf) by 65% and Cmax by 59%.1

The Mitapivat and Clindamycin Interaction, Explained

Mitapivat (Pyrukynd) can speed up an enzyme in your liver called . Clindamycin (Cleocin) is an antibiotic that your body clears partly through that same enzyme. When you take both, your body may clear clindamycin faster, so there could be less of it in your blood to fight your infection.

The worry is that the antibiotic might not work as well as it should. Watch for signs your infection is not getting better, like fever, redness, or pain that sticks around or gets worse. Keep taking both as prescribed, and let your pharmacist or doctor know you take both. Your care team can watch how you respond and adjust your treatment if needed.

Mechanism: Mitapivat is a . Clindamycin is partly by , so is expected to decrease clindamycin exposure (/) and may reduce antibacterial .

  • Magnitude: Mitapivat reduced midazolam AUC by 21% to 65% and Cmax by 19% to 59%, dose-dependently (5 to 100 mg BID). Clindamycin-specific data are not available.
  • Evidence: Probable. Onset unspecified. Severity on file: major.
  • Management: Labeling advises avoiding mitapivat with sensitive, narrow-therapeutic-index CYP3A . If coadministered, monitor for loss of therapeutic effect (clinical response, signs of persistent or worsening infection). Consider an alternative antibiotic where appropriate.

See the 3 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Mitapivat and Clindamycin Interact

The likely mechanism

of -mediated by mitapivat

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Mitapivat and Clindamycin Interaction

Your care team has a few ways to handle this combination:

  • They may monitor you more closely to make sure clindamycin is clearing your infection.
  • If needed, they may choose a different antibiotic or adjust your treatment, individualized for you.

What you can do:

  • Keep taking both medicines exactly as prescribed. Do not stop either on your own.
  • Tell your pharmacist and every prescriber that you take mitapivat.
  • Call your doctor if your infection symptoms are not improving or are getting worse.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Mitapivat or Clindamycin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: PYRUKYND oral tablets, mitapivat oral tablets

    Drug interaction studies showed that giving mitapivat together with midazolam (a sensitive ) lowered midazolam (inf) and by 21% and 19%, respectively, with mitapivat 5 mg twice daily, by 43% and 39%, respectively, with mitapivat 20 mg twice daily, and by 57% and 52%, respectively, with mitapivat 50 mg twice daily.3 In a similar manner, mitapivat 100 mg twice daily reduced midazolam AUC (inf) and Cmax by 65% and 59%, respectively.1

Mitapivat and Clindamycin: Common Questions

How serious is the Mitapivat and Clindamycin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Mitapivat and Clindamycin interaction managed?

Your care team has a few ways to handle this combination: They may monitor you more closely to make sure clindamycin is clearing your infection. If needed, they may choose a different antibiotic or adjust your treatment, individualized for you. What you can do: Keep taking both medicines exactly as prescribed. Do not stop either on your own. Tell your pharmacist and every prescriber that you take… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Mitapivat and Clindamycin Interaction

Ask in your own words about taking Mitapivat and Clindamycin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (3)

  1. Product Information: AQVESME™ oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2025. DailyMed
  2. Product Information: PYRUKYND(R) oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2022. DailyMed
  3. Product Information: PYRUKYND(R) oral tablets, mitapivat oral tablets. Agios Pharmaceuticals Inc (per FDA), Cambridge, MA, 2025. DailyMed
Was this write-up helpful?

Other Serious Interactions of Mitapivat and Clindamycin

Also serious with Clindamycin

Also serious with Mitapivat

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Clindamycin

With Mitapivat

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.